- Home
- CEV vs CBUS Comparison
CEV vs CBUS Comparison
Compare CEV & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CEV | CBUS |
|---|---|---|
| Founded | 1999 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.8M | 69.9M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | CEV | CBUS |
|---|---|---|
| Price | $10.40 | $1.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $21.25 |
| AVG Volume (30 Days) | 19.6K | ★ 141.6K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | ★ 4.23% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | N/A | ★ $3,794,000.00 |
| Revenue This Year | N/A | $17.67 |
| Revenue Next Year | N/A | $63.43 |
| P/E Ratio | $29.36 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.83 | $1.09 |
| 52 Week High | $10.91 | $4.96 |
Technical Indicators
Market Signals| Indicator | CEV | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 52.43 | 57.66 |
| Support Level | $10.33 | $1.25 |
| Resistance Level | $10.62 | $1.36 |
| Average True Range (ATR) | 0.10 | 0.12 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 31.03 | 100.00 |
Price Performance
Historical ComparisonAbout CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.